Abiopharma

🔍 Hain Robert C (Director)

Company: Armour Residential REIT, Inc. (ARR)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 1,900 shares of Common Stock, par value $0.001 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,381.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 950 shares of Common Stock, par value $0.001 per share at $16.32 per share (Direct)
  Date: 2026-08-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,431.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,900 shares of Phantom Stock (Derivative)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 28,354.00 | transaction_form_type: 4 | Footnotes: F2, F1, F1

Footnotes:

• F1: On August 21, 2026 , the reporting person elected to convert 950 of the 1,900 shares of vested phantom stock into 950 shares of ARMOUR common stock. The reporting person elected to convert the remaining 950 shares of vested phantom stock into cash solely to pay income taxes on the vested stock. The 1900 shares are part of, and relate to, phantom stock vesting over five-year periods, which was reported on Form 4 reports filed by the reporting person on February 14, 2023, December 18, 2025, and May 21, 2026.
• F2: Each unit of phantom stock is the economic equivalent of one share of ARMOUR common stock.